Journal of Hepatology
Article in Press
Received 22 December 2013; received in revised form 6 March 2014; accepted 7 March 2014. published online 18 March 2014.
Background and aims
The association between Hepatitis C virus (HCV)-infection and fracture risk is not well characterized. We compared fracture risk between HCV-seropositive (HCV-exposed) patients and the general population and between patients with cleared and chronic HCV-infection.
Outcome measures were time to first fracture at any site, time to first low-energy and first non low-energy (other) fracture in 12,013 HCV-exposed patients from the DANVIR cohort compared with a general population control cohort (n = 60,065) matched by sex and age. Within DANVIR, 4500 patients with chronic HCV-infection and 2656 patients with cleared HCV-infection were studied.
Compared with population controls, HCV-exposed patients had increased overall risk of fracture [adjusted incidence rate ratio (aIRR) 2.15, 95% Confidence Interval (CI) 2.03 – 2.28], increased risk of low-energy fracture (aIRR 2.13, 95% CI 1.93 – 2.35) and of other fracture (aIRR 2.18, 95% CI 2.02 – 2.34). Compared with cleared HCV-infection, chronic HCV-infection was not associated with increased risk of fracture at any site (aIRR 1.08, 95% CI 0.97 – 1.20), or other fracture (aIRR 1.04, 95% CI 0.91 – 1.19). The aIRR for low-energy fracture was 1.20 (95% CI 0.99 – 1.44).
HCV-exposed patients had increased risk of all fracture types. In contrast, overall risk of fracture did not differ between patients with chronic versus cleared HCV-infection, although chronic HCV-infection might be associated with a small excess risk of low-energy fractures. Our study suggests that fracture risk in HCV-infected patients is multi-factorial and mainly determined by lifestyle-related factors associated with HCV-exposure.
Abbreviations: HCV, hepatitis C virus, CI, confidence interval, aIRR, adjusted incidence rate ratio, BMD, bone mineral density, CRS, Civil Registration System, DNPR, Danish National Hospital Registry, I CD-8, International Classification of Diseases, revision 8, ICD-10, International Classification of Diseases, revision 8, IDU, intravenous drug use, CCI, Charlsons Comorbidity Index, IRR, incidence rate ratio, PY, person years of observation
No full text is available. To read the body of this article, please view the PDF online.